Latest News & Features

Reset all filters
Article Type
Channels & Sectors
Geography
Company

Refine Search
Biotechnology
The EU General Court has annulled a decision by the Community Plant Variety Office, in a dispute between a developer and distributor of sugar beet seeds and an Italy-based company.   27 November 2017
Big Pharma
MSD, known as Merck and Co in the US and Canada, announced plans to launch a life sciences discovery research facility just hours ahead of the UK government’s release of its industrial strategy.   27 November 2017
Big Pharma
The English Court of Appeal today handed down its decision in a dispute between pharmaceutical company Merck Sharp & Dohme (MSD) Corp and its German rival Merck KGaA, offering a mixed ruling.   24 November 2017
Big Pharma
The EU General Court has backed Endoceutics, a pharmaceutical company focused on women’s health, by revoking a finding that Merck KGaA had genuinely used a trademark.   23 November 2017
Big Pharma
The chief business officer of the Broad Institute of MIT and Harvard and a senior patent counsel at Novartis are just two of a number of experts who are attending the Life Sciences Patent Network Europe conference in London.   23 November 2017
Americas
Eli Lilly experienced a setback yesterday at the US Court of Appeals for the Federal Circuit when it affirmed that a patent owned by the company is invalid.   23 November 2017
Europe
A prenatal test sold by molecular diagnostics company Premaitha Health infringes patents owned by genetic sequencing firm Illumina, a UK court has ruled.   22 November 2017
Americas
A US district court has granted Swiss agribusiness Syngenta a permanent injunction against pesticide maker Willowood, two months after Syngenta secured nearly $1 million in damages from a jury verdict.   22 November 2017
Big Pharma
The European Medicines Agency will relocate from its London, UK headquarters to Amsterdam, in the Netherlands.   21 November 2017
Americas
Eli Lilly appears to be mulling whether to oppose a trademark registered by Bristol-Myers Squibb at the US Patent and Trademark Office.   21 November 2017